EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

In situ cellular hitchhiking of nanoparticles for drug delivery

Edidiong Udofa, Zongmin Zhao

Advanced Drug Delivery Reviews · 2024

DOI: 10.1016/j.addr.2023.115143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024. Verfasst von Edidiong Udofa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the inception of the concept of "magic bullet", nanoparticles have evolved to be one of the most effective carriers in drug delivery. Nanoparticles improve the therapeutic efficacy of drugs offering benefits to treating various diseases. Unlike free drugs which freely diffuse and distribute through the body, nanoparticles protect the body from the drug by reducing non-specific interactions while also improving the drug's pharmacokinetics. Despite acquiring some FDA approvals, further clinical application of nanoparticles is majorly hindered by its limited ability to overcome biological barriers resulting in uncontrolled biodistribution and high clearance. The use of cell-inspired systems has emerged as a promising approach to overcome this challenge as cells are biocompatible and have improved access to tissues and organs. One of such is the hitchhiking of nanoparticles to circulating cells such that they are recognized as 'self' components evading clearance and resulting in site-specific drug delivery. In this review, we discuss the concept of nanoparticle cellular hitchhiking, highlighting its advantages, the principles governing the process and the challenges currently limiting its clinical translation. We also discuss in situ hitchhiking as a tool for overcoming these challenges and the considerations to be taken to guide research efforts in advancing this promising technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNanoparticlesHumansTissue DistributionPharmaceutical PreparationsNanomedicine

Stichwörter der Autor:innen

BiomimeticCell carrierCell-based drug deliveryCellular hitchhikingNanomedicineNanoparticle

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL 60612, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL 60612, USA; Translational Oncology Program, University of Illinois Cancer Center, Chicago, IL 60612, USA. Electroni…

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Udofa, E., & Zhao, Z. (2024). In situ cellular hitchhiking of nanoparticles for drug delivery. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.115143

Vancouver

Udofa E, Zhao Z. In situ cellular hitchhiking of nanoparticles for drug delivery. Advanced Drug Delivery Reviews. 2024. doi:10.1016/j.addr.2023.115143

BibTeX
@article{Udofa2024,
  author = {Udofa, Edidiong and Zhao, Zongmin},
  title = {In situ cellular hitchhiking of nanoparticles for drug delivery},
  journal = {Advanced Drug Delivery Reviews},
  year = {2024},
  doi = {10.1016/j.addr.2023.115143}
}
Kostenlos starten →